Can I Take Ginseng with Jardiance (Empagliflozin)?

What Is the Interaction Between Ginseng and Jardiance?

The interaction is pharmacodynamic, not pharmacokinetic. Both agents lower blood glucose by different mechanisms, and their effects add together rather than one changing how the body processes the other chemically. Empagliflozin blocks the sodium-glucose cotransporter 2 (SGLT2) in the proximal renal tubule, causing urinary excretion of roughly 70 g of glucose per day at the 10 mg dose [1]. Ginseng, particularly American ginseng (Panax quinquefolius), independently reduces post-prandial blood glucose through insulin secretagogue activity and improved peripheral glucose uptake [2].

No published pharmacokinetic study shows that ginsenosides meaningfully alter cytochrome P450 2C9, 3A4, or the transporters responsible for empagliflozin clearance at standard supplement doses. The concern is almost entirely about blood-glucose overlap.

Pharmacokinetics of Empagliflozin

Empagliflozin reaches peak plasma concentration in 1.5 hours, has a terminal half-life of roughly 12.4 hours, and is eliminated primarily via glucuronidation and renal excretion [1]. None of the major glucuronidation enzymes (UGT1A3, UGT2B7) are significantly inhibited by ginsenosides at doses used in clinical trials [3].

How Ginseng Lowers Glucose

A randomized, double-blind, placebo-controlled crossover trial by Vuksan et al. (N=19 healthy adults) found that 3 g of American ginseng taken 40 minutes before a 25 g oral glucose load reduced the 2-hour glucose area-under-the-curve by 20% compared with placebo (P<0.05) [2]. A follow-up trial in 10 patients with type 2 diabetes replicated the finding and showed that the timing of ginseng relative to meals matters: taking it more than 2 hours before a meal blunts the effect [4].

Why Additive Lowering Matters for Jardiance Users

Empagliflozin alone carries a low intrinsic hypoglycemia risk because SGLT2 inhibition is glucose-dependent. However, the combination of empagliflozin plus a sulfonylurea, insulin, or ginseng shifts the risk curve upward. The EMPA-REG OUTCOME trial (N=7,020) reported hypoglycemia events in roughly 28% of participants on background insulin versus 8.3% on non-insulin agents [5]. Adding a glucose-active supplement to an already complex regimen compounds that gap.

Is Ginseng Safe to Take with Jardiance?

For most patients taking empagliflozin without insulin or a sulfonylurea, adding a standardized ginseng supplement at studied doses (3 g per meal of American ginseng) is unlikely to cause clinically significant hypoglycemia. The risk is low-to-moderate rather than absolute. Patients using concurrent insulin or sulfonylureas face a meaningfully higher risk and need explicit prescriber guidance before adding ginseng.

Assessing Your Individual Risk

Three factors determine how much the combination matters for a specific patient.

Background diabetes regimen. Empagliflozin monotherapy carries less hypoglycemia risk than combination regimens. The American Diabetes Association 2024 Standards of Care classify SGLT2 inhibitors as agents with "low hypoglycemia risk" when used without secretagogues [6].

Ginseng dose and preparation. There is no regulatory standardization for over-the-counter ginseng products in the United States. The FDA does not require supplement manufacturers to demonstrate efficacy or consistent ginsenoside content before sale [7]. A product labeled "500 mg ginseng extract" may contain anywhere from 1% to 10% ginsenosides, translating to wildly different pharmacologic activity.

Baseline glycemic control. Patients with HbA1c values near target (below 7%) have less glucose buffer to absorb additive lowering than patients who are running hyperglycemic.

Signs of Hypoglycemia to Watch For

Hypoglycemia symptoms include shakiness, sweating, confusion, rapid heartbeat, and pallor. The American Diabetes Association defines clinically significant hypoglycemia as a blood glucose below 54 mg/dL [6]. During the first 4 weeks of combined use, self-monitoring of blood glucose before breakfast and 2 hours after the largest meal provides the most useful safety data.

What Is Panax Ginseng Versus American Ginseng?

These are related but pharmacologically distinct plants. Panax ginseng (Asian or Korean ginseng) contains a different ginsenoside ratio than Panax quinquefolius (American ginseng). Most of the controlled glycemic data come from American ginseng. Panax ginseng has less consistent evidence for glucose lowering but carries a separate concern: its potential to inhibit platelet aggregation [8].

The Anticoagulant Dimension

A study published in Clinical Pharmacology and Therapeutics found that Panax ginseng reduced warfarin area-under-the-curve by 34% in healthy volunteers, apparently through CYP2C9 or P-glycoprotein induction [9]. For patients on Jardiance who also use warfarin, aspirin, rivaroxaban, or apixaban, adding Asian ginseng introduces a second interaction layer unrelated to blood glucose.

Empagliflozin itself has no direct anticoagulant mechanism, but patients with heart failure or CKD taking the drug often carry cardiovascular comorbidities that place them on antiplatelet or anticoagulant therapy. The anticoagulant-ginseng interaction therefore applies to a large share of the Jardiance-using population.

Which Ginseng Products Have Clinical Trial Data?

The best-studied formulation for glycemic effects is CVT-E002, a proprietary American ginseng root extract used in the Vuksan trials [2][4]. Most pharmacy-shelf ginseng supplements are not this product and have not been tested in diabetes populations. If you are trying to replicate the trial results, ask your pharmacist about the specific extract used rather than choosing any generic ginseng capsule.

Mechanism Deep Dive: How SGLT2 Inhibition and Ginsenosides Overlap

Understanding the mechanistic overlap helps clinicians and patients make a proportionate risk assessment rather than a binary yes-or-no decision.

SGLT2 Inhibition Pathway

Empagliflozin competitively and reversibly blocks SGLT2, which normally reabsorbs approximately 90% of filtered glucose in the S1 and S2 segments of the proximal tubule [1]. The result is glucosuria of 70 to 90 g per day at steady state, translating to roughly 280 to 360 kcal of daily caloric loss. Blood glucose falls because glucose that would re-enter systemic circulation is excreted instead.

Ginsenoside Pathway

Ginsenosides Rb1, Rg1, and compound K have been shown in cell and animal models to stimulate insulin secretion from pancreatic beta cells, enhance GLUT4 translocation to skeletal muscle membranes, and inhibit intestinal glucose absorption [3]. The net effect in humans is a reduction in post-prandial glucose, particularly in the first 2 hours after a carbohydrate-containing meal.

Where the Pathways Converge

Both mechanisms ultimately reduce circulating blood glucose, but they do so at different points in glucose physiology. SGLT2 inhibition acts on the kidney after glucose has already entered systemic circulation. Ginsenosides act earlier, reducing glucose entry from the gut and increasing peripheral disposal. The two effects do not cancel each other; they stack. A patient who runs a fasting glucose of 120 mg/dL on empagliflozin alone may see their fasting glucose drop to 95 to 105 mg/dL when American ginseng is added at 3 g per meal, which is within normal range but leaves less margin before the hypoglycemia threshold.

Clinical Monitoring Plan When Combining Ginseng and Jardiance

Your prescriber should be informed before you start ginseng. If they confirm it is appropriate, the following monitoring schedule is reasonable for a low-risk patient (empagliflozin without insulin or sulfonylurea, HbA1c between 7% and 9%).

• Weeks 1 to 4: Self-monitor blood glucose fasting and 2 hours post-prandial at least 3 days per week.
• Month 3: HbA1c and a basic metabolic panel including serum creatinine (already standard for empagliflozin follow-up per prescribing information) [1].
• Month 6: Repeat HbA1c. If HbA1c drops below 6.5%, discuss with your prescriber whether empagliflozin dose reduction is appropriate.
• Ongoing: Review ginseng product label at each refill. Formulations and ginsenoside concentrations vary between lots.

Patients on warfarin who add any ginseng species should have an INR checked within 7 to 10 days and then again at 30 days, given the potential enzyme-induction effect on warfarin metabolism [9].

What the Prescribing Label Says

The FDA-approved prescribing information for empagliflozin does not list ginseng as a named drug interaction [1]. The label does state that co-administration with insulin or insulin secretagogues may require dose reduction of those agents to reduce hypoglycemia risk. Ginseng is not a secretagogue in the pharmacological sense, but its functional glucose-lowering activity means the same physiological caution applies even if the regulatory label does not address it directly.

The Natural Medicines Database (formerly Natural Medicines Comprehensive Database) rates the ginseng-blood glucose lowering drug combination as a "moderate" interaction, advising monitoring but not absolute avoidance [10]. The label language from that database reads: "Theoretically, concomitant use of American ginseng with antidiabetic drugs might cause additive effects and increase the risk of hypoglycemia. Monitor blood glucose closely." [10]

Special Populations

Heart Failure and CKD Patients

Empagliflozin is approved for heart failure with reduced ejection fraction and for CKD based on the EMPEROR-Reduced (N=3,730) and EMPA-KIDNEY (N=6,609) trials [11][12]. Patients in these populations are more likely to be on complex drug regimens including loop diuretics, renin-angiotensin-aldosterone system blockers, and sometimes anticoagulants. Ginseng's antiplatelet effect and its variable ginsenoside content make supplement counseling more pressing in these groups. Discuss any supplement with your cardiologist or nephrologist, not just your diabetes prescriber.

Older Adults

Adults over 65 years have impaired counter-regulatory responses to hypoglycemia, meaning they may not feel classic warning symptoms until glucose is dangerously low. The Beers Criteria from the American Geriatrics Society caution against any unnecessary hypoglycemia risk in older adults [13]. If you are over 65 and taking Jardiance, the bar for adding a glucose-active supplement should be higher.

Pregnancy

Empagliflozin is not recommended during pregnancy. Ginseng safety in pregnancy has not been established in controlled trials, and traditional use data are conflicting [7]. Neither agent should be taken during pregnancy without explicit specialist guidance.

Practical Steps If You Are Already Taking Both

Some patients discover this combination issue after they have already been taking ginseng alongside Jardiance for weeks or months. If that describes you, there is no immediate emergency in most cases, but take these steps.

1. Check your blood glucose today and for the next 3 to 5 days at multiple time points.
2. Call or message your prescriber to disclose the combination; bring the exact product label including brand name, dose, and ginsenoside percentage.
3. Do not abruptly stop empagliflozin. Stopping an SGLT2 inhibitor without medical direction removes cardiovascular and renal protection established in large outcome trials [5][11].
4. If you experience shakiness, sweating, confusion, or a glucose reading below 70 mg/dL, treat with 15 g of fast-acting glucose (4 glucose tablets or 4 oz orange juice) and contact your care team.

How to Choose a Safer Ginseng Product If Your Prescriber Approves Use

Not all ginseng products are equal. The following criteria reduce variability and align with the preparations that have clinical trial data.

• Species: American ginseng (Panax quinquefolius) has the strongest glycemic evidence and less anticoagulant concern than Asian Panax ginseng.
• Dose: 3 g of root extract per meal, taken 40 minutes before eating, mirrors the Vuksan trial protocol [2].
• Standardization: Look for products standardized to a declared ginsenoside percentage (4% to 8% is typical for American ginseng root).
• Third-party testing: NSF Certified for Sport, USP Verified, or Informed Sport seals indicate the product has been independently tested for label accuracy and contaminants.
• Avoid combination products: Ginseng is frequently sold in "energy" or "immune" blends with caffeine, adaptogens, or other actives that add unpredictable interactions on top of the glucose effect.